After his military service, Gov. Bevin worked for many years in the financial industry. A job opportunity brought Gov. Bevin and his wife, Glenna, a registered nurse, to Kentucky 17 years ago, when they decided to put down roots and raise their family.
Gov. Bevin has founded several companies in Kentucky and invested in a number of others in the Commonwealth and around the United States. He has managed and expanded multiple businesses, creating many good paying jobs for hard working Americans. These companies range from manufacturing to investment management to medical devices.
Ambassador Brownfield was sworn in as Assistant Secretary for International Narcotics and Law Enforcement Affairs (INL) on January 10, 2011. As Assistant Secretary for INL, he is responsible for State Department programs combating illicit drugs and organized crime, as well as support for law enforcement and rule of law. INL currently manages a portfolio of more than $4 billion in more than 80 countries administered by 5000 employees and contractors.
Prior to his appointment, Ambassador Brownfield served as U.S. Ambassador to Colombia from 2007 to 2010. Prior to that, he served as U.S. Ambassador to Venezuela (2004-07) and U.S. Ambassador to Chile (2002-04). He has also served overseas in Venezuela, El Salvador, Argentina, Switzerland, and Panama as temporary Political Adviser to the U.S. Southern Command.
In Washington his jobs have included Deputy Assistant Secretary for Western Hemisphere Affairs, Deputy Assistant Secretary for International Narcotics and Law Enforcement, Director for Policy and Coordination in INL, Executive Assistant to the Bureau of Inter-American Affairs, Member of the Secretary’s Policy Planning Staff, and Special Assistant to the Under Secretary for Political Affairs.
Ambassador Brownfield holds the personal rank of Career Ambassador, the highest rank in the U.S. Foreign Service. He has received the Secretary of State’s Distinguished Service Award and the Presidential Performance Award three times. Ambassador Brownfield is a graduate of Cornell University (1974) and the National War College (1993). He attended the University of Texas School of Law (1976-78). He speaks Spanish and French. He is a native of the State of Texas.
A committed public servant, Buddy previously served as the Mayor of Pooler, Georgia and in the Georgia General Assembly where he used his business experience to make government more efficient and responsive to the people. Buddy is serving his second term in the United States House of Representatives and is a member of the Committee on Energy and Commerce. As the only pharmacist serving in Congress, Buddy is the co-chair of the Community Pharmacy Caucus and is dedicated to working towards a health care system that provides more choices, less costs and better services.
A lifelong resident of the First District, Buddy was born and raised in Port Wentworth, Georgia and is a proud graduate of Young Harris College and the University of Georgia where he earned his Bachelor of Science in Pharmacy. Buddy married his college sweetheart, Amy, 38 years ago. Buddy and Amy now reside in Pooler, Georgia and have three sons, two daughters-in-law and three grandchildren.
Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.
Before coming to NIH, Dr. Collins was a Howard Hughes Medical Institute investigator at the University of Michigan. He is an elected member of the Institute of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009.
Since 2011, Ms. Enomoto has provided leadership on agency operations, policies, and programmatic activities while serving in a number of senior management roles, including Acting Administrator and Principal Deputy Administrator. During her tenure at SAMHSA, she has also served as the Director of the Office of Policy, Planning and Innovation, Acting Deputy Administrator, and as the Principal Senior Advisor to three SAMHSA Administrators. Ms. Enomoto joined SAMHSA in 1998 as a Presidential Management Fellow after spending her early career in research and clinical services with a focus on minority mental health and trauma.
Ms. Enomoto has received awards in recognition of her work, including the Arthur S. Flemming Award, the American College of Mental Health Administration King Davis Award, and the Secretary’s Award for Distinguished Service.
Ms. Enomoto earned her bachelor’s degree in psychology and master’s degree in clinical psychology from the University of California, Los Angeles, and is a graduate of Harvard University’s Kennedy School of Government, Senior Managers in Government Program.
Born and raised in the federal housing project of Mayberry Village in East Hartford, John is fond of saying he is the product of public housing, public education, and public service. His father, Raymond, worked for Pratt & Whitney, while his mother, Pauline, served on the Town Council. John graduated from East Hartford High School in 1967 and from Central Connecticut State University (CCSU) in 1971.
Before entering Congress, John taught history and coached football at George J. Penney High School. He was also an owner of Larson & Lysik insurance company, where he saw firsthand the challenges many small business owners must overcome. Following in his mother's footsteps, serving on the East Hartford Board of Education and the East Hartford Town Council. In 1982, he was elected to the Connecticut State Senate, beginning a 12-year tenure representing the 3rd Senate District until 1995. Larson served as Senate President Pro Tempore for eight years from 1987 to 1995.
From May 2016 to January 2017, Dr. Ostroff served as the Food and Drug Administration's Deputy Commissioner for Foods and Veterinary Medicine. In that role, he oversaw the food and animal health activities of FDA, including FDA's responsibilities in the areas of food safety and nutrition, food labeling, food and color additives, cosmetics, dietary supplements, animal drugs and animal feed, and research to support the food and veterinary medicine mission of FDA.
Dr. Ostroff previously served as the acting FDA Commissioner from April 2015 to late February 2016.
Before being named acting commissioner, Dr. Ostroff served as the FDA's Chief Scientist starting in February 2014. The Office of the Chief Scientist works closely with FDA's product centers, providing strategic leadership and support for FDA's regulatory science and innovation initiatives.
Dr. Ostroff joined FDA in 2013 as Chief Medical Officer in the Center for Food Safety and Applied Nutrition and Senior Public Health Advisor to FDA's Office of Foods and Veterinary Medicine.
Prior to that, he served as Deputy Director of the National Center for Infectious Diseases at the Centers for Disease Control and Prevention (CDC). At CDC Dr. Ostroff focused on emerging infectious diseases, food safety, and coordination of complex outbreak response. He retired from the Commissioned Corps of the U.S. Public Health Service at the rank of Rear Admiral (Assistant Surgeon General). Dr. Ostroff was also the Director of the Bureau of Epidemiology and Acting Physician General for the Commonwealth of Pennsylvania and has consulted internationally on public health projects in South Asia and Latin America.
Dr. Ostroff graduated from the University of Pennsylvania School of Medicine in 1981 and completed residencies in internal medicine at the University of Colorado Health Sciences Center and preventive medicine at CDC.
Dr. Schuchat played key roles in CDC emergency responses including the 2009 H1N1 pandemic influenza response, the 2003 SARS outbreak in Beijing and the 2001 bioterrorist anthrax response. Globally, she has worked on meningitis, pneumonia and Ebola vaccine trials in West Africa, and conducted surveillance and prevention projects in South Africa.
Dr. Schuchat graduated from Swarthmore College and Dartmouth Geisel School of Medicine and completed her residency and chief residency in internal medicine at NYU’s Manhattan VA Hospital. She was promoted to Rear Admiral in the Commissioned Corps of the United States Public Health Service in 2006 and earned a second star in 2010.
Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction.
Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. Her studies have documented changes in the dopamine system affecting, among others, the functions of frontal brain regions involved with motivation, drive, and pleasure in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.
Dr. Volkow was born in Mexico, attended the Modern American School, and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned the Laughlin Fellowship Award as one of the 10 Outstanding Psychiatric Residents in the USA.
Dr. Volkow spent most of her professional career at the Department of Energy’s Brookhaven National Laboratory (BNL) in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. In addition, Dr. Volkow was a Professor in the Department of Psychiatry and Associate Dean of the Medical School at the State University of New York (SUNY)-Stony Brook.
Dr. Volkow has published more than 600 peer-reviewed articles and written more than 95 book chapters and non-peer-reviewed manuscripts, and has also edited three books on neuroimaging for mental and addictive disorders.During her professional career, Dr. Volkow has been the recipient of multiple awards. In 2013, she was a Samuel J. Heyman Service to America Medal (Sammies) finalist; and she was inducted into the Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Hall of Fame. She was elected to membership in the Institute of Medicine in the National Academy of Sciences and received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science. She has been named one of Time magazine’s “Top 100 People Who Shape Our World,” “One of the 20 People to Watch” by Newsweek magazine, Washingtonian magazine’s “100 Most Powerful Women” and “Innovator of the Year” by U.S. News & World Report.